| Product NDC: | 68220-160 |
| Proprietary Name: | Dipentum |
| Non Proprietary Name: | olsalazine sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; olsalazine sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68220-160 |
| Labeler Name: | Alaven Pharmaceutical LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019715 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19900731 |
| Package NDC: | 68220-160-10 |
| Package Description: | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (68220-160-10) |
| NDC Code | 68220-160-10 |
| Proprietary Name | Dipentum |
| Package Description | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (68220-160-10) |
| Product NDC | 68220-160 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | olsalazine sodium |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 19900731 |
| Marketing Category Name | NDA |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | OLSALAZINE SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |